CeriBell, Inc. Revenue
CeriBell, Inc. (CBLL) reported Revenue of $28.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-10
- CeriBell, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $28.10M, a 32.54% increase year-over-year.
- CeriBell, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $26.49M, a 29.30% increase year-over-year.
- CeriBell, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $24.78M, a 33.72% increase year-over-year.
- CeriBell, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $22.59M, a 31.37% increase year-over-year.
- CeriBell, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $89.06M, a 36.09% increase from fiscal 2024.
- CeriBell, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $65.44M, a 44.71% increase from fiscal 2023.
- CeriBell, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $45.23M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.10M 10-Q · filed 2026-08-10 | $54.59M 10-Q · filed 2026-08-10 | $79.38M derived: sum of 3 quarters · filed 2026-08-10 | $101.96M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $26.49M 10-Q · filed 2026-05-11 | $51.28M derived: sum of 2 quarters · filed 2026-05-11 | $73.87M derived: sum of 3 quarters · filed 2026-05-11 | $95.07M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $24.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $47.37M derived: sum of 2 quarters · filed 2026-02-24 | $68.57M derived: sum of 3 quarters · filed 2026-08-10 | $89.06M 10-K · filed 2026-02-24 |
| 2025-09-30 | $22.59M 10-Q · filed 2025-11-04 | $43.79M derived: sum of 2 quarters · filed 2026-08-10 | $64.28M 10-Q · filed 2025-11-04 | $82.81M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $21.20M 10-Q · filed 2026-08-10 | $41.69M 10-Q · filed 2026-08-10 | $60.22M derived: sum of 3 quarters · filed 2026-08-10 | $77.42M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $20.49M 10-Q · filed 2026-05-11 | $39.02M derived: sum of 2 quarters · filed 2026-05-11 | $56.22M derived: sum of 3 quarters · filed 2026-05-11 | $71.53M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $18.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $35.73M derived: sum of 2 quarters · filed 2026-02-24 | $51.04M derived: sum of 3 quarters · filed 2026-02-24 | $65.44M 10-K · filed 2026-02-24 |
| 2024-09-30 | $17.20M 10-Q · filed 2025-11-04 | $32.51M derived: sum of 2 quarters · filed 2025-11-04 | $46.91M 10-Q · filed 2025-11-04 | $60.04M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $15.31M 10-Q · filed 2025-08-05 | $29.71M 10-Q · filed 2025-08-05 | $42.85M derived: sum of 3 quarters · filed 2025-08-05 | $54.46M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $14.40M 10-Q · filed 2025-05-08 | $27.53M derived: sum of 2 quarters · filed 2025-05-08 | $39.14M derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $13.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $24.74M derived: sum of 2 quarters · filed 2025-02-25 | $45.23M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $11.61M 10-Q · filed 2024-11-12 | $32.09M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |